1. Field of the Invention
Embodiments of the invention relate generally to the field of assemblies of anisotropic nanoparticles. Some embodiments of the invention relate to the field of highly aligned assemblies of anisotropic nanoparticles. Some embodiments of the invention relate to impurity distributed assemblies of anisotropic nanoparticles. More particularly, some embodiments of the invention relate to compositions of matter including highly aligned, impurity distributing anisotropic nanoparticles and methods of making structures including highly aligned, impurity distributing anisotropic nanoparticles.
2. Discussion of the Related Art
Topotaxy is known to those skilled in the art of materials science. The term ‘topotaxy’ was defined by Lotgering and Gorter to include “all chemical solid state reactions that lead to a material with crystal orientations which are correlated with crystal orientations in the initial product”.
A problem with this technology has been that the production of a dimensionally large material shape requires a correspondingly large initial product. One unsatisfactory approach, in an attempt to solve the above-discussed problem involves the use of a single crystal as the initial product. However, a disadvantage of this approach is that for a given material of interest, a single crystal initial product having appropriate lattice parameters, that is also of the desired size and shape may not be available. Another disadvantage of this approach has been that even if an appropriately sized and shaped single crystal initial product is available, it may be prohibitively expensive for use as a chemical reactant. Therefore, what is needed is a solution that provides initial products having the necessary lattice parameters that are also of suitable size and shape. What is also needed is a solution that meets the above-discussed requirements in a more cost-effective manner.
Meanwhile, it has been known in the field of materials science to utilize impurities to facilitate chemical reactions. Also impurities may be desirable in a final product, as in most semiconductor devices. The nature and extent of the effect of the impurities depends on their concentration, location and interactions with the host material(s).
A problem with this technology is that providing beneficial impurities in the proper concentration and location (e.g., homogeneously throughout a reactant/reaction) can be difficult and/or expensive. For instance, ion implantation is spatially accurate and precise, but it is very expensive. Another problem with this technology is that impurities can diffuse, thereby exacerbating concentration and location issues, especially in liquid and/or gas state reactions. Therefore, what is needed is a solution that provides a beneficial impurity in the correct location and at a precise concentration. What is also needed is a solution that provides a beneficial impurity introduction method that is resistant to undesirable diffusion.
Heretofore, the requirements of providing 1) initial products for topotaxy that have the necessary size, shape and lattice parameters and 2) beneficial impurities in the correct location and concentration that are resistant to undesirable diffusion have not been fully met. What is needed is a solution that solves all of these problems.
There is a need for the following embodiments of the invention. Of course, the invention is not limited to these embodiments.
According to an embodiment of the invention, a composition of matter comprises: a plurality of anisotropic nanoparticles that are in physical contact with one another, each of the plurality of anisotropic nanoparticles having a) a first dimension that is substantially different than both a second dimension and a third dimension and b) a non-random nanoparticle crystallographic orientation that is substantially aligned with the first direction, wherein the plurality of anisotropic nanoparticles are substantially aligned with respect to each other to define a substantially close packed dense layer having a non-random shared crystallographic orientation that is substantially aligned with a basal plane of the substantially close packed dense layer. According to another embodiment of the invention, a process comprises: forming a substantially close packed dense layer by assembling a plurality of anisotropic nanoparticles, each of the plurality of anisotropic nanoparticles having a) a first dimension that is substantially different than both a second dimension and a third dimension and b) a non-random nanoparticle crystallographic orientation that is substantially aligned with the first direction, wherein assembling includes mechanically interacting the plurality of anisotropic nanoparticles by imposing a delocalized force that defines a direction that is substantially perpendicular to a basal plane of the substantially closed packed dense layer; and imposing a fluctuating force to which the anisotropic nanoparticles respond, wherein fluctuations in a magnitude of the imposed force are sufficient to overcome a short range weak attractive force between members of the plurality of anisotropic nanoparticles with respect to anisotropic nanoparticles that are not substantially overlapping, wherein the plurality of anisotropic nanoparticles are substantially aligned with respect to each other to define the substantially close packed dense layer and the substantially closed packed dense layer has a non-random shared crystallographic orientation that is substantially aligned with the basal plane of the substantially close packed dense layer.
These, and other, embodiments of the invention will be better appreciated and understood when considered in conjunction with the following description and the accompanying drawings. It should be understood, however, that the following description, while indicating various embodiments of the invention and numerous specific details thereof, is given for the purpose of illustration and does not imply limitation. Many substitutions, modifications, additions and/or rearrangements may be made within the scope of an embodiment of the invention without departing from the spirit thereof, and embodiments of the invention include all such substitutions, modifications, additions and/or rearrangements.
The drawings accompanying and forming part of this specification are included to depict certain embodiments of the invention. A clearer concept of embodiments of the invention, and of components combinable with embodiments of the invention, and operation of systems provided with embodiments of the invention, will be readily apparent by referring to the exemplary, and therefore nonlimiting, embodiments illustrated in the drawings (wherein identical reference numerals (if they occur in more than one view) designate the same elements). Embodiments of the invention may be better understood by reference to one or more of these drawings in combination with the following description presented herein. It should be noted that the features illustrated in the drawings are not necessarily drawn to scale.
Embodiments of the invention and the various features and advantageous details thereof are explained more fully with reference to the nonlimiting embodiments that are illustrated in the accompanying drawings and detailed in the following description. Descriptions of well known starting materials, processing techniques, components and equipment are omitted so as not to unnecessarily obscure the embodiments of the invention in detail. It should be understood, however, that the detailed description and the specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only and not by way of limitation. Various substitutions, modifications, additions and/or rearrangements within the spirit and/or scope of the underlying inventive concept will become apparent to those skilled in the art from this disclosure.
Within this application several publications are referenced by Arabic numerals, or principal author's name followed by year of publication, within parentheses or brackets. Full citations for these, and other, publications may be found at the end of the specification immediately preceding the claims after the section heading References. The disclosures of all these publications in their entireties are hereby expressly incorporated by reference herein for the purpose of indicating the background of embodiments of the invention and illustrating the state of the art.
In general, the context of embodiments of the invention can include the assembly of anisotropic nanoparticles. The context of an embodiment of the invention can include preparing chemical reactant containing precursors for pressure contained processing. The context of an embodiment of the invention can also include further processing and incorporating the corresponding chemical products into devices such as photodiodes (e.g., photovoltaics).
The invention can utilize liquid precursors that include solid state nanoparticles to form a substantially close packed dense layer having a non-random shared crystallographic orientation that is substantially aligned with a basal plane of the substantially close packed dense layer. The substantially closed packed dense layer can be characterized by a packing factor that is within at least 25%, 20%, 15%, 10%, 5%, 1%, 0.5%, or 0.1% of a maximum packing factor. The liquid precursor can include solvents, dispersants and surfactant in addition to the solid state nanoparticles.
The invention can include a first set of anisotropic nanoparticles and a second set of anisotropic nanoparticles, wherein the first set of anisotropic nanoparticles and the second set of anisotropic nanoparticles are different from one another with regard to at least one state variable selected from the group consisting of principle plane plan, minor plane profile, impurity presence, electrostatic edge charge, electrostatic surface charge, edge acidity, surface acidity, edge hydrophilicity and surface hydrophilicity. The invention can include a plurality of isotropic nanoparticles coupled to the plurality of anisotropic nanoparticles.
The invention can include anisotropic nanoparticles that include (In,Ga)y(S,Se)1-y. The invention can include anisotropic nanoparticles that includes Cux(Se)1-x. The invention can include anisotropic nanoparticles that include Cu(In,Ga)y(S,Se)1-y. The invention can include a substrate coupled to the substantially close packed dense layer. The invention can include a plurality of anisotropic nanoparticles that are fused.
Referring to
Referring to
The delocalized force cam include gravity, magnetic, electrostatic and/or electromagnetic. The invention can include stabilizing the non-random shared crystallographic orientation. Stabilizing can include fusing the plurality of anisotropic nanoparticles. Stabilizing can include changing a chemical composition of the substantially closed packed dense layer. Changing the chemical composition can include volatilization of a solvent. Stabilizing can include changing a local ionic concentration within the substantially close packed dense layer by forming a Helmholtz double layer, wherein the substantially close packed dense layer is located in one layer of the Helmholtz double layer. The plurality of anisotropic nanoparticles can include polar crystals. Stabilizing can include changing a composition of a medium that is coupled to the substantially close packed dense layer. Stabilizing can include changing a pH of a medium that is coupled to the substantially closed packed dense layer.
The short range weak attractive force can includes Van der Waals attractive forces. Imposing the fluctuating force can include exciting the plurality of anisotropic nanoparticles with at least one activation energy source selected from the group consisting of electric, magnetic, electrostatic, electromagnetic, ultrasonic, acoustic and actinic.
The invention can include providing a plurality of isotropic nanoparticles coupled to the plurality of anisotropic nanoparticles and imposing the fluctuating force on the isotropic nanoparticles. Assembling can include arranging the plurality of anisotropic nanoparticles to have a local impurity concentration by volume of no more than approximately 25% different than an average impurity concentration by volume with respect to the substantially close packed dense layer. In a preferred embodiment, the local impurity concentration is sodium per unit volume.
The invention can include recrystallizing the substantially close packed dense layer. The invention can include chemically reacting the substantially close packed dense layer with a chemical reactant to yield a chemical product. Chemically reacting can result in topotactic growth of the substantially close packed dense layer. Chemically reacting can include exerting a pressure that is sufficient to substantially prevent escape of vapor from the substantially close packed dense layer, the chemical reactant and the chemical product.
The invention can include generating an electric field across the substantially close packed dense layer, the chemical reactant and the chemical product. In a preferred embodiment, the chemical product includes Cu(In,Ga)y(S,Se)1-y.
Embodiments of the invention can utilize data processing methods that transform near real-time signals from the nanoparticles undergoing processing to control/optimize that processing. For example, an embodiment of the invention can be combined with instrumentation to obtain state variable information representing the degree of alignment of the nanoparticles to actuate interconnected discrete hardware elements. For instance, an embodiment of the invention can include the use signals reflected from the nanoparticles undergoing alignment and/or a substrate upon which the alignment is taking place to characterize the achieved degree of alignment and thereby control the magnitude and duration of excitation from one or more mechanical interaction activation energy sources including electric, magnetic, electrostatic, electromagnetic (e.g., RF), acoustic (e.g., ultrasonic) and/or actinic (e.g., UV).
Embodiments of the invention can include highly aligned structures of anisotropic nanoparticles. The anisotropic nanoparticles can have lattice parameters suitable for use as topotaxy reactants (initial products). By utilizing nanoparticles whose parameters are orientated in accord with their anisotropy, and then aligning a plurality of these nanoparticles, an initial product for topotaxy of deterministic size and shape can be fabricated.
The invention can include the use of nanoparticles that are manufactured using organic surfactant-nanoparticle interactions. Nanoparticles can be passivated or “capped” with long chain organic ligands and/or surfactants. Organic surfactants play a key role in determining the size and shape of nanoparticles during synthesis.[1] Preferential surface adhesion of ligands to crystal facets is critical in the growth and shape of the nanoparticle. Direct empirical observation of selective adhesion of surfactants has not been observed during nanocrystal growth, but theoretical studies and first-principles calculations support this mechanism.[1,2,3] Those facets most strongly bound to ligands are the slowest to grow. The relative ligand binding energy to different facets controls the relative growth rates of those facets and thus the resulting geometry.[3] If the nanocrystals have a highly symmetric crystal structure (e.g., Zn blend or rock-salt), synthesis frequently yields faceted crystals with no unique dimension of growth.[2] Polar facets are less stable and less efficiently passivated than nonpolar facets, which can rationalize the observed anisotropic growth mechanism of wurtzite nanocrystals.[2] For instance, In2Se3 can form a stable wurtzite structure, which can yield a hexagonal rod particle under appropriate conditions. The degree of surfactant coverage or surfactant density on a facet and the monomer density also affect the growth mechanism.[2]
The invention can also include the use of manufactured core/shell systems, for instance, involving the bonding of inorganic materials to nanoparticles. Nanocrystals capped by inorganic species can be referred to as “core/shell” systems. Examples of these systems include CdSe/CdS, Si/SiO2, CdS/Cd(OH)2, CdSe/ZnSe, CdSe/ZnS and CdS/HgS/CdS.[4] Most of the systems studied are II-VI semiconductors that exhibit unique photoluminescent properties. The core nanocrystals are ˜5 nm in diameter and the shells, which grow epitaxially on the core are ˜0.5 nm in thickness.[4,5]The capping appears to occur uniformly over the nanocrystal and is not related to any specific crystallographic facet. Several conditions for depositing these materials exist, which include (1) the core must withstand the conditions under which the shell is deposited (2) the surface energies of the two phases must be similar so that the barrier for heterogeneous nucleation of the shell is lower than that for homogeneous nucleation and (3) the seed nanocrystal and the shell must not readily interdiffuse under the deposition conditions.[6]
The invention can also include the use of controlled morphology of Cu—In—Ga—Se nanoparticle compounds. The morphologies and dimensions of various Cu—In—Ga—Se nanoparticles are listed in the following table.
The invention can include anisotropic nanoparticles that are arranged to define an order having three-dimensional translational periodicity and a rotational symmetry that is 4-fold with respect to a normal to a basal plane of the substantially close packed dense layer. The invention can include anisotropic nanoparticles that are arranged to define an order having three-dimensional translational periodicity and a rotational symmetry that is 6-fold with respect to a normal to a basal plane of the substantially close packed dense layer.
The invention can include the use of quasicrystal nanoparticles. The invention can utilize quasicrystals that are quasiperiodic in two dimensions (i.e., polygonal or dihedral quasicrystals).
In this case there is one periodic direction perpendicular to the quasiperiodic layers. These types include: octagonal quasicrystals with local 8-fold symmetry [primitive & body-centered lattices]; decagonal quasicrystals with local 10-fold symmetry [primitive lattice]; and dodecagonal quasicrystals with local 12-fold symmetry [primitive lattice]. The invention can include quasicrystals that define a rotational symmetry that is 10-fold with respect to a basal plane of the substantially close packed dense layer, a one-dimensional translational periodicity that is perpendicular to the basal plane, and that are ordered with respect to basal spatial location on a scale that is substantially a multiple of approximately five nanometers.
The invention can utilize quasicrystals that are quasiperiodic in three dimensions. In this case there is no periodic direction. These types include: icosahedral quasicrystals (axes:12×5-fold, 20×3-fold, 30×2-fold) [primitive, body-centered & face-centered lattices]; and “icosahedral” quasicrystal with broken symmetry (stable binary Cd5.7Yb).
Examples of octagonal quasicrystals include: V—Ni—Si; Cr—Ni—Si; Mn—Si; Mn—Si—Al; and Mn—Fe—Si. Examples of decagonal quasicrystals include: Al—TM (where TM=Ir, Pd, Pt, Os, Ru, Rh, Mn, Fe, Co, Ni, Cr); Al—Ni—Co*; Al—Cu—Mn; Al—Cu—Fe; Al—Cu—Ni; Al—Cu—Co*; Al—Cu—Co—Si*; Al—Mn—Pd*; V—Ni—Si; and Cr—Ni. Examples of dodecagonal quasicrystals include: Cr—Ni; V—Ni; and V—Ni—Si. Examples of icosahedral quasicrystals include: Al—Mn; Al—Mn—Si; Al—Li—Cu*; Al—Pd—Mn*; Al—Cu—Fe; Al—Mg—Zn; Zn—Mg—RE* (where RE═La, Ce, Nd, Sm, Gd, Dy, Ho, Y); Ti-TM (where TM=Fe, Mn, Co, Ni); Nb—Fe; V—Ni—Si; and Pd—U—Si. In this paragraph, the use of “*” indicates that stable phases exist.
A perfectly aligned structure of anisotropic nanoparticles can have a free energy that is as low as a theoretical lowest free energy with respect to the structure. Embodiments of the invention can have a free energy no more than approximately 90, 80, 70, 60, 50, 40, 30, 20, 10, 5, or 1 percent above a theoretical lowest free energy with respect to the structure.
While not being limited to any particular performance indicator or diagnostic identifier, preferred embodiments of the invention can be identified one at a time by testing for the presence of spatially resolved gaps between the nanoparticles. The test for the presence of alignment can be carried out without undue experimentation by the use of a simple and conventional transmitting electron microscopy experiment.
Embodiments of the invention can include impurity distributed structures of anisotropic nanoparticles. By providing an impurity at a controlled location on the surface of an anisotropic nanoparticle, and then arranging a plurality of such nanoparticles. the impurity can be distributed within the structure defined by the plurality of nanoparticles.
The invention can include anisotropic nanoparticles that include an impurity and have a local impurity concentration by volume of no more than 25% different than an average impurity concentration by volume with respect to the substantially close packed dense layer. A preferred embodiment of the invention is directed to a local impurity concentration of sodium per unit volume.
Some embodiments of the invention can include locating an impurity within the interior of a nanoparticle. Alternatively, some embodiments of the invention can include locating the impurity at the surface of a nanoparticle. In the case of nanoparticle platelets or circular x-section rods, or hexagonal x-section rods that are going to be arranged in a basal plane, it can be advantageous to locate the impurity at the edge of the platelets so that the impurity is distributed at the nanoparticle interfaces. For instance, sodium can be provided on the surface of (In,Ga)y(S,Se)1-y, Cux(Se)1-x. or Cu(In,Ga)y(S,Se)1-y. nanoparticles by providing the sodium in the form of a surfactant, for example sodium bis(2-ethylhexyl)sulphosuccinate) or diisooctyl sodium sulfosuccinate or sodium dodecylsulphate (SDS) or Sodium Lauryl Sulfate (SLS). It can be appreciated that these surfactants can provide the sodium on the surface (e.g., edge) of the nano-particles(-platelets) while simultaneously stabilizing the growth of the particles (platelets). Alternatively, impurities can be provided on the surface by ligand exchange. Such an exchange can include exposure (optionally repeatedly) to an excess competing capping group, followed by precipitation to isolate the partially exchanged nanoparticles.
A structure with a perfectly distributed impurity can have a local impurity concentration that is the same as an average impurity concentration by volume with respect to the structure. Embodiments of the invention can have a local impurity concentration by volume of no more than approximately 90, 80, 70, 60, 50, 40, 30, 20, 10, 5, or 1 percent different than an average impurity concentration by volume with respect to the structure.
While not being limited to any particular performance indicator or diagnostic identifier, preferred impurity distributed embodiments of the invention can be identified one at a time by testing for the spatially resolved presence of the impurity element(s). The test for the presence of alignment can be carried out without undue experimentation by the use of a simple and conventional scanning probe microscopy experiment.
Specific embodiments of the invention will now be further described by the following, nonlimiting examples which will serve to illustrate in some detail various features. The following examples are included to facilitate an understanding of ways in which an embodiment of the invention may be practiced. It should be appreciated that the examples which follow represent embodiments discovered to function well in the practice of the invention, and thus can be considered to constitute preferred mode(s) for the practice of the embodiments of the invention. However, it should be appreciated that many changes can be made in the exemplary embodiments which are disclosed while still obtaining like or similar result without departing from the spirit and scope of an embodiment of the invention. Accordingly, the examples should not be construed as limiting the scope of the invention.
Referring to
Referring to
Referring to
Referring to
A practical application of an embodiment of the invention that has value within the technological arts is preparing a chemical precursor layer for subsequent use in a chemical reaction, for example, a pressure contained chemical reaction that includes one or more trace moieties (for instance a surfactant) that are advantageously homogeneously distributed in the precursor layer. Further, embodiments of the invention are useful in conjunction with preparing dye sublimation plates (such as are used for the purpose of printing), or in conjunction with nano fabrication techniques (such as are used for the purpose of quantum device manufacture), or the like. There are virtually innumerable uses for embodiments of the invention, all of which need not be detailed here.
Embodiments of the invention can be cost effective and advantageous for at least the following reasons. Embodiments of the invention improve quality and/or reduce costs compared to previous approaches.
The phrase aspect ratio is intended to mean the ratio of length to average of height and width with respect to a (nano)particle. The phrase principal plane is intended to mean the plane located by a normal that is parallel to the shortest dimension of a (nano)particle. The phrase local impurity concentration by volume is intended to mean the amount of an impurity per unit volume in the vicinity of a group of (e.g., 10-100) nanoparticles; and not proximate an individual nanoparticle or adjacent a nearest neighbor nanoparticle. The phrase average impurity concentration by volume is intended to mean the amount of an impurity within a bulk defined by the plurality of anisotropic nanoparticles. The phrase ultrasonic frequency is intended to mean frequencies greater than or equal to approximately 20 KHz. The phrase radio frequency is intended to mean frequencies less than or equal to approximately 300 GHz as well as the infrared spectrum. Group numbers corresponding to columns within the periodic table of the elements use the “New Notation” convention as seen in the CRC Handbook of Chemistry and Physics, 81st Edition (2000).
The term substantially is intended to mean largely but not necessarily wholly that which is specified. The term approximately is intended to mean at least close to a given value (e.g., within 10% of). The term generally is intended to mean at least approaching a given state. The term coupled is intended to mean connected, although not necessarily directly, and not necessarily mechanically. The term proximate, as used herein, is intended to mean close, near adjacent and/or coincident; and includes spatial situations where specified functions and/or results (if any) can be carried out and/or achieved. The term distal, as used herein, is intended to mean far, away, spaced apart from and/or non-coincident, and includes spatial situation where specified functions and/or results (if any) can be carried out and/or achieved.
The terms first or one, and the phrases at least a first or at least one, are intended to mean the singular or the plural unless it is clear from the intrinsic text of this document that it is meant otherwise. The terms second or another, and the phrases at least a second or at least another, are intended to mean the singular or the plural unless it is clear from the intrinsic text of this document that it is meant otherwise. Unless expressly stated to the contrary in the intrinsic text of this document, the term or is intended to mean an inclusive or and not an exclusive or. Specifically, a condition A or B is satisfied by any one of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present). The terms a and/or an are employed for grammatical style and merely for convenience.
The term plurality is intended to mean two or more than two. The term any is intended to mean all applicable members of a set or at least a subset of all applicable members of the set. The phrase any integer derivable therein is intended to mean an integer between the corresponding numbers recited in the specification. The phrase any range derivable therein is intended to mean any range within such corresponding numbers. The term means, when followed by the term “for” is intended to mean hardware, firmware and/or software for achieving a result. The term step, when followed by the term “for” is intended to mean a (sub)method, (sub)process and/or (sub)routine for achieving the recited result.
The terms “comprises,” “comprising,” “includes,” “including,” “has,” “having” or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. The terms “consisting” (consists, consisted) and/or “composing” (composes, composed) are intended to mean closed language that does not leave the recited method, apparatus or composition to the inclusion of procedures, structure(s) and/or ingredient(s) other than those recited except for ancillaries, adjuncts and/or impurities ordinarily associated therewith. The recital of the term “essentially” along with the term “consisting” (consists, consisted) and/or “composing” (composes, composed), is intended to mean modified close language that leaves the recited method, apparatus and/or composition open only for the inclusion of unspecified procedure(s), structure(s) and/or ingredient(s) which do not materially affect the basic novel characteristics of the recited method, apparatus and/or composition.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present specification, including definitions, will control.
The described embodiments and examples are illustrative only and not intended to be limiting. Although embodiments of the invention can be implemented separately, embodiments of the invention may be integrated into the system(s) with which they are associated. All the embodiments of the invention disclosed herein can be made and used without undue experimentation in light of the disclosure. Although the best mode of the invention contemplated by the inventor(s) is disclosed, embodiments of the invention are not limited thereto. Embodiments of the invention are not limited by theoretical statements (if any) recited herein. The individual steps of embodiments of the invention need not be performed in the disclosed manner, or combined in the disclosed sequences, but may be performed in any and all manner and/or combined in any and all sequences. The individual components of embodiments of the invention need not be formed in the disclosed shapes, or combined in the disclosed configurations, but could be provided in any and all shapes, and/or combined in any and all configurations. The individual components need not be fabricated from the disclosed materials, but could be fabricated from any and all suitable materials. Homologous replacements may be substituted for the substances described herein.
It can be appreciated by those of ordinary skill in the art to which embodiments of the invention pertain that various substitutions, modifications, additions and/or rearrangements of the features of embodiments of the invention may be made without deviating from the spirit and/or scope of the underlying inventive concept. All the disclosed elements and features of each disclosed embodiment can be combined with, or substituted for, the disclosed elements and features of every other disclosed embodiment except where such elements or features are mutually exclusive. The spirit and/or scope of the underlying inventive concept as defined by the appended claims and their equivalents cover all such substitutions, modifications, additions and/or rearrangements.
The appended claims are not to be interpreted as including means-plus-function limitations, unless such a limitation is explicitly recited in a given claim using the phrase(s) “means for” and/or “step for.” Subgeneric embodiments of the invention are delineated by the appended independent claims and their equivalents. Specific embodiments of the invention are differentiated by the appended dependent claims and their equivalents.
Number | Name | Date | Kind |
---|---|---|---|
3629036 | Isaacson | Dec 1971 | A |
4088544 | Hutkin | May 1978 | A |
4267398 | Rothwarf | May 1981 | A |
4315097 | Solomon | Feb 1982 | A |
4322571 | Stanbery | Mar 1982 | A |
4392451 | Mickelsen et al. | Jul 1983 | A |
4523051 | Mickelsen et al. | Jun 1985 | A |
RE31968 | Mickelsen et al. | Aug 1985 | E |
4571448 | Barnett | Feb 1986 | A |
4611091 | Choudary et al. | Sep 1986 | A |
4674434 | Ishihara | Jun 1987 | A |
4823176 | Baliga et al. | Apr 1989 | A |
4902395 | Yoshimura | Feb 1990 | A |
5028274 | Basol et al. | Jul 1991 | A |
5055150 | Rosenfeld et al. | Oct 1991 | A |
5124308 | Albin et al. | Jun 1992 | A |
5124309 | Albin et al. | Jun 1992 | A |
5178967 | Rosenfeld et al. | Jan 1993 | A |
5248621 | Sano | Sep 1993 | A |
5298449 | Kikuchi | Mar 1994 | A |
5396839 | Rice | Mar 1995 | A |
5405802 | Yamagata et al. | Apr 1995 | A |
5436204 | Albin et al. | Jul 1995 | A |
5441897 | Noufi et al. | Aug 1995 | A |
5477088 | Rockett et al. | Dec 1995 | A |
5477288 | Miyazaki et al. | Dec 1995 | A |
5567469 | Wada et al. | Oct 1996 | A |
5578503 | Karg et al. | Nov 1996 | A |
5626688 | Probst et al. | May 1997 | A |
5674555 | Birkmire et al. | Oct 1997 | A |
5705011 | Bodford et al. | Jan 1998 | A |
5730852 | Bhattacharya et al. | Mar 1998 | A |
5756240 | Roberts et al. | May 1998 | A |
5858121 | Wada et al. | Jan 1999 | A |
5858628 | Yoshida et al. | Jan 1999 | A |
5948176 | Ramanathan et al. | Sep 1999 | A |
6072818 | Hayakawa | Jun 2000 | A |
6100165 | Sakaguchi et al. | Aug 2000 | A |
6121541 | Arya | Sep 2000 | A |
6146979 | Henley et al. | Nov 2000 | A |
6187653 | Hui et al. | Feb 2001 | B1 |
6190453 | Boydston et al. | Feb 2001 | B1 |
6225199 | Han et al. | May 2001 | B1 |
6251754 | Ohshima et al. | Jun 2001 | B1 |
6313479 | Zhang et al. | Nov 2001 | B1 |
6323417 | Gillespie et al. | Nov 2001 | B1 |
6372538 | Wendt et al. | Apr 2002 | B1 |
6399486 | Chen et al. | Jun 2002 | B1 |
6455398 | Fonstad, Jr. et al. | Sep 2002 | B1 |
6475354 | Toyama | Nov 2002 | B1 |
6500733 | Stanbery | Dec 2002 | B1 |
6521511 | Inoue et al. | Feb 2003 | B1 |
6559372 | Stanbery | May 2003 | B2 |
6593213 | Stanbery | Jul 2003 | B2 |
6669830 | Inoue et al. | Dec 2003 | B1 |
6720239 | Stanbery | Apr 2004 | B2 |
6736986 | Stanbery | May 2004 | B2 |
6787012 | Stanbery | Sep 2004 | B2 |
6797874 | Stanbery | Sep 2004 | B2 |
6852920 | Sager et al. | Feb 2005 | B2 |
6855202 | Alivisatos et al. | Feb 2005 | B2 |
6881647 | Stanbery | Apr 2005 | B2 |
6936761 | Pichler | Aug 2005 | B2 |
6987071 | Bollman et al. | Jan 2006 | B1 |
7045205 | Sager | May 2006 | B1 |
7097902 | Blanton et al. | Aug 2006 | B2 |
7422696 | Mirkin et al. | Sep 2008 | B2 |
20020006470 | Eberspacher et al. | Jan 2002 | A1 |
20020043279 | Karg | Apr 2002 | A1 |
20030051664 | Stanbery | Mar 2003 | A1 |
20030052391 | Stanbery | Mar 2003 | A1 |
20030054582 | Stanbery | Mar 2003 | A1 |
20030054662 | Stanbery | Mar 2003 | A1 |
20030054663 | Stanbery | Mar 2003 | A1 |
20030123167 | Kolberg et al. | Jul 2003 | A1 |
20030201010 | Koyanagi et al. | Oct 2003 | A1 |
20040063320 | Hollars | Apr 2004 | A1 |
20040250848 | Sager et al. | Dec 2004 | A1 |
20050095422 | Sager et al. | May 2005 | A1 |
20050098204 | Roscheisen et al. | May 2005 | A1 |
20050098205 | Roscheisen et al. | May 2005 | A1 |
20050109392 | Hollars | May 2005 | A1 |
20050121068 | Sager et al. | Jun 2005 | A1 |
20050183767 | Yu et al. | Aug 2005 | A1 |
20050183768 | Roscheisen et al. | Aug 2005 | A1 |
20050186342 | Sager et al. | Aug 2005 | A1 |
20050218377 | Lawandy | Oct 2005 | A1 |
20060062902 | Sager et al. | Mar 2006 | A1 |
20070077429 | Mirkin et al. | Apr 2007 | A1 |
20070119522 | Grier et al. | May 2007 | A1 |
20070152236 | Halpert et al. | Jul 2007 | A1 |
20070163642 | Van Duren et al. | Jul 2007 | A1 |
20070234949 | Ahn et al. | Oct 2007 | A1 |
20070261951 | Ye et al. | Nov 2007 | A1 |
20080138501 | Yu et al. | Jun 2008 | A1 |
20080142083 | Yu et al. | Jun 2008 | A1 |
20080164239 | Mirkin et al. | Jul 2008 | A1 |
20080194103 | Wagner | Aug 2008 | A1 |
20080242088 | Suzuki | Oct 2008 | A1 |
20090226603 | Lowrey | Sep 2009 | A1 |
Number | Date | Country |
---|---|---|
4225385 | Jul 1992 | DE |
4225385 | Feb 1994 | DE |
0381509 | Feb 1990 | EP |
381509 | Aug 1990 | EP |
0621130 | Apr 1994 | EP |
0661760 | Dec 1994 | EP |
61760 | Jul 1995 | EP |
0763859 | Sep 1996 | EP |
763859 | Mar 1997 | EP |
0763859 | Mar 1997 | EP |
621130 | Nov 1997 | EP |
0989593 | Sep 1999 | EP |
989593 | Mar 2000 | EP |
1255305 | Jun 2002 | EP |
1385365 | Mar 2005 | EP |
WO9722152 | Jun 1997 | WO |
WO 9722152 | Jun 1997 | WO |
WO 0033363 | Jun 2000 | WO |
WO0033363 | Jun 2000 | WO |
WO 03002225 | Jan 2003 | WO |
WO 03026022 | Mar 2003 | WO |
WO 03026023 | Mar 2003 | WO |
WO 03026024 | Mar 2003 | WO |
WO 03026025 | Mar 2003 | WO |
WO 03026026 | Mar 2003 | WO |
WO 03026028 | Mar 2003 | WO |
WO 2005017978 | Feb 2005 | WO |
WO 2005059952 | Jun 2005 | WO |
WO2006041199 | Apr 2006 | WO |
WO 2006133129 | Dec 2006 | WO |
WO 2006133129 | Dec 2006 | WO |
WO 2007082080 | Jul 2007 | WO |
WO 2007082084 | Jul 2007 | WO |
WO 2007082085 | Jul 2007 | WO |
WO 2008027571 | Mar 2008 | WO |
Number | Date | Country | |
---|---|---|---|
20080311028 A1 | Dec 2008 | US |